Detalhe da pesquisa
1.
The safety and immunogenicity of a bivalent conjugate vaccine against Salmonella enterica Typhi and Paratyphi A in healthy Indian adults: a phase 1, randomised, active-controlled, double-blind trial.
Lancet
; 403(10436): 1554-1562, 2024 Apr 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38555928
2.
Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults.
Hum Vaccin Immunother
; 20(1): 2304974, 2024 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-38512394
3.
Post-marketing safety surveillance of the rotavirus vaccine in India.
Vaccine X
; 15: 100362, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37593522
4.
Active safety surveillance of rabies monoclonal antibody and rabies vaccine in patients with category III potential rabies exposure.
Lancet Reg Health Southeast Asia
; 14: 100207, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37492421
5.
Safety and Immunogenicity of SARS-CoV-2 Recombinant Spike Protein Vaccine in Children and Adolescents in India: A Phase 2-3 Randomized Clinical Trial.
JAMA Pediatr
; 2023 Jul 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37523166
6.
A Phase 3, randomized, non-inferiority study of a heterologous booster dose of SARS CoV-2 recombinant spike protein vaccine in adults.
Sci Rep
; 13(1): 16579, 2023 10 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37789040
7.
Safety and immunogenicity of SII-NVX-CoV2373 (COVID-19 vaccine) in adults in a phase 2/3, observer-blind, randomised, controlled study.
Lancet Reg Health Southeast Asia
; 10: 100139, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36647543
8.
A case control study to assess effectiveness of measles containing vaccines in preventing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in children.
Hum Vaccin Immunother
; 17(10): 3316-3321, 2021 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34128766
9.
A phase 2/3, participant-blind, observer-blind, randomised, controlled study to assess the safety and immunogenicity of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine) in adults in India.
EClinicalMedicine
; 42: 101218, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-34870133
10.
Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants.
Vaccine
; 37(19): 2554-2560, 2019 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30955982
11.
Safety and tolerability of a liquid bovine rotavirus pentavalent vaccine (LBRV-PV) in adults.
Vaccine
; 36(12): 1542-1544, 2018 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29439867
12.
A Phase III open-label, randomized, active controlled clinical study to assess safety, immunogenicity and lot-to-lot consistency of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Vaccine
; 36(52): 7943-7949, 2018 12 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-30420116
13.
Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine.
Vaccine
; 36(37): 5519-5523, 2018 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30104114
14.
A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.
Vaccine
; 35(45): 6228-6237, 2017 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-28967523
15.
Response to: Letter from P. Gillard and B. Benninghoff.
Vaccine
; 37(23): 2991-2992, 2019 05 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-31072468